Skip to Content

NeutriSci International Inc 1N9

Morningstar Rating
CAD 0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

1N9 is trading at a 856% premium.
Price
€0.00
Fair Value
€9.54
Uncertainty
Extreme
1-Star Price
€4.45
5-Star Price
€2.32
Economic Moat
Ffbd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 1N9 is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 0.00
Day Range
CAD 0.000.00
52-Week Range
CAD 0.000.24
Bid/Ask
CAD 0.00 / CAD 0.00
Market Cap
CAD 89,212.13
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NeutriSci International Inc is a Canada-based company engaged in the market development of nutraceutical products. The company's revenue consists of sales of the Neueenergy product line.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
1N9
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
2.11
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
1N9
Quick Ratio
0.01
Current Ratio
0.02
Interest Coverage
−246.40
Quick Ratio
1N9

Profitability

Metric
1N9
Return on Assets (Normalized)
−242.22%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
1N9
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
FnbrswgqZtfcfpr$80.3 Bil
Zoetis Inc Class A
ZTS
VwzcnvkcrPylz$77.8 Bil
Haleon PLC ADR
HLN
XghfhfmqCwsd$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
MvvnvslpZzxpt$12.1 Bil
Viatris Inc
VTRS
HdgbvkbdJxws$12.1 Bil
Catalent Inc
CTLT
NlxwcsfjsBqxfdy$10.0 Bil
Perrigo Co PLC
PRGO
FbkcmghyXwwn$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
GkryncgqTzbdwk$3.2 Bil
Curaleaf Holdings Inc
CURLF
PvfntpspDnd$3.0 Bil
Green Thumb Industries Inc
GTBIF
YqfxrjjfKjs$2.7 Bil

Sponsor Center